XM3LR7ICD-11 MMS 2026-01
Predominantly alpha-adrenoreceptor agonists
Index terms
- Predominantly alpha-adrenoreceptor agonists
- Agonist predominantly alpha-adrenoreceptor
Child codes
XM0AN5– CetoximeXM0CL2– PseudoephedrineXM0W81– AntistineXM0Y33– ClemizoleXM2305– HomochlorcyclizineXM25T0– Apraclonidine (hydrochloride)XM29D4– DifenidolXM2V55– PhenyltoloxamineXM35M7– BenzquinamideXM39Y4– ThenyldiamineXM4PH8– ChlorothenXM4TB9– Levocabastine (hydrochloride)XM59T1– EmbramineXM62B0– DibenzheptropineXM66X7– Chlor-TrimetonXM6XN3– PhenylpropanolamineXM6ZQ3– PhenylephrineXM7D21– ParedrineXM7RF2– MoxastineXM81D8– NorepinephrineXM88Z7– Bisulepin (hydrochloride)XM8TK4– MethaphenileneXM8Y26– CyclopentamineXM8ZH9– Dimenhydrinate
Sibling codes
XM36U7– Alpha- and beta-adrenoreceptor agonists
Foundation entity
Predominantly alpha-adrenoreceptor agonists – http://id.who.int/icd/entity/464753737
Part of: XM6CH2: Drugs primarily affecting the autonomic nervous system › XM6S30: Medicaments › X: Extension Codes